Thermo Fisher develops single system for biopharmaceutical characterisation

Thermo Fisher Scientific has developed a new single system that enables three powerful workflows for researchers performing biopharmaceutical characterisation.

The American biotechnology product development company named the tech Thermo Scientific Q Exactive BioPharma MS/MS Hybrid Quadropole-Orbitrap. The mass spectrometer harnesses the high-resolution, accurate-mass (HRAM) capabilities of the Orbitrap mass analyser.
This, says Thermo Fisher Scientific, enables three key protein characterisation workflows – denatured and native MS intact analysis, subunit and top/middle-down analysis and peptide mapping.
“Researchers require multiple MS techniques to perform the experiments essential for biopharmaceutical structure characterisation,” said Jonathan Josephs, director, pharma/biopharma marketing, life sciences mass spectrometry at Thermo Fisher.
“We now offer a single instrument that encompasses all of our leading technologies into one system, which can be used to analyse antibody-based biologics at the intact, subunit, and peptide levels—ultimately providing an efficient route to high quality results.”
Thermo Fisher Scientific is set to display the tech at:

• The 64th American Society of Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics at the Henry B. Gonzalez Convention Center in the Thermo Fisher Booth 319;
• And in the Thermo Fisher suite at the Grand Hyatt Hotel, Texas Ballroom D

For more information, visit: http://www.thermofisher.com/asms

Author

Phill Allen

Managing Director

Phill is an innovative thinker particularly in fluid management. His expertise lies in ensuring the seamless flow of pharmaceutical liquid logistics, whether it's optimising current processes or pioneering new approaches.

Follow me